Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection

NCT03399903 is registered in ClinicalTrials.gov with AIDS Healthcare Foundation as lead sponsor.

NCT NCT03399903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03399903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
Lead sponsor
AIDS Healthcare Foundation
Phase
Phase 1/2
Overall status
Completed
Start date
May 1, 2017
Completion date
March 22, 2019
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gut inflammation, hiv-1-infection